Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer

Journal of Gastrointestinal Surgery

Volumn 6, Issue 1, 2002, Pages 88-94

  Little, Sarah A ^a   Jarnagin, William R ^a   DeMatteo, Ronald P ^a   Blumgart, Leslie H ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Diabetes mellitus; Hepatic resection; Steatosis

Indexed keywords

FLUOROURACIL; FOLINIC ACID; INSULIN; LEVAMISOLE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BILE LEAKAGE; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DATA BASE; FATTY LIVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HEMOPERITONEUM; HEPATORENAL SYNDROME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOPERATIVE PERIOD; LIVER FAILURE; LIVER INJURY; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERITONITIS; POSTOPERATIVE INFECTION; RESPIRATORY TRACT DISEASE; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; FOLLOW UP; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROBABILITY; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0036360105     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00019-1     Document Type: Article

References (21)

1. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to the remnant liver volume. J Am Coll Surg 1998;188:304-307.
2. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 2001;27:1567-1571.
3. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997;73:204-207.
4. Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 1957;105:310-318.
5. Couinaud C. Bases anatomiques des hepatectomies gauche et droite reglees. J Chirurg 1954;70:933-966.
6. Hoofhagle JH, Carithers RL, Shapiro AM, Asch N. Fulminant hepatic failure: Summary of a workshop. Hepatology 1995;21:240-252.
7. Matthews DE, Farewell VT. Understanding Medical Statistics. New York: Karger, 1990.
8. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-481.
9. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;187-220.
10. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998;187:620-625.
11. Cruse PJE, Foord R. A five-year-prospective study of 23,649 surgical wounds. Arch Surg 1973;107:206-210.
12. Yanaga K, Kanematsu T, Takenaka K, Sugimachi K. Intraperitoneal septic complications after hepatectomy. Ann Surg 1986;203:148-152.
13. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, Sugimachi K. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 1998;85:195-198.
14. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, Brown S. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989;169:17-26.
15. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992;163:515-518.
16. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, Bonalumi MG. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 1995;82:377-381.
17. Kohli V, Madden J, Clavien PA. Failure of regeneration in the steatotic rat liver: A possible mechanism for poor outcomes after major tissue loss and transplantation. Hepatology 1998;28(4 part 2):525A.
18. Behms KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney D. Hepatic steatosis as a potential risk factor for major hepatic resection. J GASTROINTEST SURG 1998;2:292-298.
19. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995;21:434-439.
20. Adami H, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF Jr. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-1477.
21. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos, Adami H. Role of diabetes mellitus in the etilogy of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-1099.